Hippocampal volume
|
I-1
|
Age
|
− 23.01 (− 28.71~ − 17.30)
|
− 0.414
|
< 0.001**
|
Gender
|
96.58 (− 9.99~203.15)
|
0.099
|
0.076
|
Educational level
|
− 3.93 (− 15.21~7.35)
|
− 0.038
|
0.494
|
APOEε4
|
− 174.78 (− 331.62~ − 17.93)
|
− 0.114
|
0.029*
|
Dyslipidemia
|
167.05 (58.20~275.89)
|
0.159
|
0.003**
|
Hippocampal volume
|
I-2
|
Age
|
− 22.67 (− 28.45~ − 16.88)
|
− 0.408
|
< 0.001**
|
Gender
|
89.25 (−17.90~196.40)
|
0.091
|
0.102
|
Educational level
|
− 1.97 (− 13.24~9.29)
|
− 0.019
|
0.731
|
APOEε4
|
− 158.91 (− 316.83~ − 1.00)
|
− 0.104
|
0.049*
|
Dyslipidemia: Group 3a
|
90.55 (9.06~172.04)
|
0.116
|
0.030*
|
White matter hyperintensity
|
II
|
Age
|
0.024 (0.017~0.032)
|
0.345
|
< 0.001**
|
Gender
|
− 0.129 (− 0.268~0.010)
|
− 0.104
|
0.068
|
Educational level
|
− 0.004 (− 0.019~0.011)
|
− 0.030
|
0.601
|
APOEε4
|
0.094 (−0.111~0.299)
|
0.048
|
0.4368
|
Hypertension
|
0.174 (0.040~0.309)
|
0.139
|
0.011*
|
Statin therapy
|
− 0.236 (− 0.386~ − 0.086)
|
− 0.167
|
0.002**
|